Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-12

Clinical Trial Update: Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay

View source ↗

Summary

This document provides an update on validating a saliva-based Fragile X assay developed by Esoterix Genetic Laboratories. The study aims to validate saliva as a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Esoterix Genetic Laboratories, LLC | Conditions: Fragile X Syndrome | Status: UNKNOWN